Slowly progressive spastic paraplegia due to rare mitochondrial dysfunction: a clinical case
Objective: To present a case of spastic paraparesis associated to a rare mitochondrial disorder. Background: Metabolic disorders may have a clinical course overlapping common neurodegenerative…Wearable sensors are able to identify individuals in the prodromal phase of X-linked Dystonia-Parkinsonism
Objective: To identify subclinical changes of balance and gait in patients with X-linked dystonia-parkinsonism (XDP) and non-manifesting carriers of the XDP-causing mutation. Background: XDP is…Dystonia due to GM3 synthase deficiency
Objective: GM3 synthase deficiency has been rarely reported to cause dystonia. We report three cases of affected siblings involving a prominent dystonic phenotype. Background: Gangliosides…GNAO1 related movement disorders: 2 longitudinally-followed cases
Objective: To describe the clinical course, phenomenology, and treatment response in two patients with GNAO1 related movement disorders. Background: Since the initial report of 4…Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?
Objective: To test whether The Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III (Motor Examination) items provide increased sensitivity…Validation of the Thai version of the MDS-UPDRS
Objective: To validate the Thai translation of the MDS-sponsored revision of the UPDRS (MDS-UPDRS). Background: The MDS-UPDRS was published in 2008 to assess different domains…Reliability and Validity of the Greek Translation of the Scale for Assessment and Rating Ataxia in Ataxic Children
Objective: Translation and Cross-cultural adaptation of the Scale for Assessment and Rating Ataxia (SARA) in Greek ataxic pediatric population. Background: Ataxia in the pediatric population…MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS
Objective: To summarize the status of the ongoing MDS-sponsored translation programs for non-English versions of the MDS-UPDRS, UDysRS, and MDS-NMS. Background: The MDS-UPDRS, UDysRS, and…The satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s disease
Objective: To explore a new rating tool to assess satisfaction with life and treatment (SLTS-7) in a PD population. Background: The satisfaction with life and in…Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)
Objective: To implement the first 3 phases of the scale development process that will create the PD-MAS. Background: Drug therapy is a central strategy in…
- « Previous Page
- 1
- …
- 810
- 811
- 812
- 813
- 814
- …
- 1734
- Next Page »